The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWCH.L Regulatory News (WCH)

  • There is currently no data for WCH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim results for the 6 months ended 31 Dec 2019

27 Mar 2020 07:00

RNS Number : 7927H
Wilmcote Holdings PLC
27 March 2020
 

LEI number: 2138004EUUU11OVHZW75

Wilmcote Holdings plc

("Wilmcote" or the "Company")

Interim Report for the six months ended 31 December 2019

27 March 2020

Wilmcote announces its interim results for the six months ended 31 December 2019.

The Interim Report is also available on the 'Shareholder Documents' page of the Company's website at www.wilmcoteplc.com.

Enquiries:

WilmcoteTel: +44(0)207 004 2700Mark Brangstrup WattsJames Corsellis

Numis Securities LimitedTel: +44(0)207 260 1000Kevin CruickshankJamie Loughborough

WILMCOTE HOLDINGS PLC

Unaudited InterimCondensed Consolidated Financial Statementsfor the six months ended 31 December 2019

MANAGEMENT REPORT

I present to shareholders the unaudited interim condensed consolidated financial statements of Wilmcote Holdings plc (the "Company") for the six months ended 31 December 2019 (the "Consolidated Interim Financial Statements"), consolidating the results of Wilmcote Holdings plc, WHJ Limited, Wilmcote Group Limited, WCH Group Limited, Arrow US Holdings Inc and Arrow Canadian Holdings Limited (collectively, the "Group" or "Wilmcote").

StrategyWilmcote was established and admitted to trading on AIM with the objective of creating value for its shareholders through the acquisition and subsequent development of target businesses, initially considering opportunities in the downstream and specialty chemicals sector.

Since listing on AIM in 2017, we have reviewed and engaged with a substantial number of potential acquisition opportunities in the specialty chemicals sector, including businesses with links to the construction, building products and broader industrial sectors. During this period, we progressed two potential acquisitions, under exclusivity, to within days of a successful completion. The financial consequences of these aborted transactions have been significant, and these have accounted for the vast majority of the Group's expenditure.

During the period of due diligence and negotiation with these two potential acquisitions in particular, we had significant ongoing dialogue with existing and potential investors (in both cases with more than 50 investors wall-crossed for material periods of time). While we were not able to subsequently conclude either of these acquisitions, each of them, remain in our view, high quality businesses in specialist segments.

While we recognise that there remains a risk of future losses arising from the pursuit of future transactions, a key priority for us will be to manage the Company's exposure to the financial costs of progressing and securing a successful acquisition. Alongside the existing risk procedures, we will further mitigate these risks by:

· reducing the target size of potential acquisitions to consider taking one or more controlling or non-controlling stakes, in businesses with an enterprise value generally expected to be up to £500 million;

· seeking appropriate risk-sharing measures with professional service providers and, to the extent possible, with vendors;

· continuing the model of early stage market sounding and consultation with potential investors throughout the transaction process; and

· maintaining a flexible attitude to which international capital markets/exchanges would provide the optimal environment for initial and future capital raising.

In December 2019, we secured additional equity funding of £6.5 million through an open offer to existing shareholders. This included support both from our cornerstone investor, Marwyn, as well as from other existing shareholders. These funds have secured a platform from which to respond quickly to opportunistic investment prospects which we continue to see in the specialty chemicals sector, as well as in the market in general, while also providing a listed vehicle to attract a new sector-leading management team in advance of an acquisition.

At the December 2019 AGM, shareholders also approved expanding the Company's investment policy to consider opportunities in adjacent sectors, reflecting the breadth of deal flow seen and a broader range of potential investment structures.

Revised Investment Policy

It is anticipated that the Company will acquire controlling or non-controlling stakes in one or more businesses or companies (quoted or private) on a long-term basis. The investments made may be in the form of equity or other types of capital investment. Subject to the structure of the transaction, the Company may need to raise additional funds for the acquisition in the form of equity and/or debt. Depending on the composition of the Company's share register at that time, it is possible that any equity fundraising for those purposes will, subject to the necessary shareholder approval, be carried out on a non-pre-emptive basis to allow for the diversification of the Company's shareholder register and to obtain sufficient equity funding.

The Company intends to focus on the industrials, manufacturing, engineering, construction, building products and support services sectors. We believe that opportunities exist to create value for shareholders through a properly executed, acquisition-led strategy in one of these sectors. We may either seek to recruit sector-leading executive management in advance of an acquisition, or alternatively may consider identifying acquisition opportunities with impressive incumbent management teams that require a catalyst to unlock growth.

Following the completion of an acquisition, the Directors intend to use their multiple years of experience alongside an executive management team to deliver value through the application of a strategy to achieve attractive, compounding returns for shareholders.

Since listing on AIM in August 2017, the Group has pursued its stated strategy to identify and analyse potential acquisition targets and consequently the Group has no reported revenue. Although the Company has not completed an acquisition to date, we are confident that the Company will be able to implement the revised investment policy in the medium term, with the proceeds from the open offer used to fund future operating expenses and due diligence to continue to pursue acquisition opportunities.

ResultsThe Group's loss after taxation for the six months to 31 December 2019 was £1,721,000 (six months to 31 December 2018: loss of £1,681,000). The Group held a cash balance at the period end of £6,450,000 (As at 30 June 2019: £7,525,000).

Dividend Policy

The Company has not yet acquired a trading operation and it is therefore inappropriate to make a forecast of the likelihood of any future dividends. The Directors intend to determine the Company's dividend policy following completion of a platform acquisition and, in any event, will only commence the payment of dividends when it becomes commercially prudent to do so.

Corporate Governance

In line with the London Stock Exchange's AIM Rules for Companies requiring all AIM-quoted companies to adopt a recognised corporate governance code, explain how the company complies with that code's requirements and identify and explain areas of non-compliance, the Board has adopted the Quoted Companies Alliance Corporate Governance Code (the "QCA Code"). There have been no significant changes to the Corporate Governance Report presented in the Group's Annual Report and Consolidated Financial Statements for the period ended 30 June 2019, which is available on the Company's website, www.wilmcoteplc.com. Additional information in respect of the Company's compliance with the QCA Code can also be found on the Company's website.

The Company intends to re-evaluate its corporate governance code framework upon the earlier of the completion of a platform acquisition, or on appointment of an executive management team.

Risks

The Directors have carried out a robust assessment of the principal risks facing the Group including those that would threaten its business model, future performance, solvency or liquidity. There have been no significant changes to the principal risks described on pages 47-53 of the Group's Annual Report and Consolidated Financial Statements for the period ended 30 June 2019. The Directors are of the opinion that the risks are applicable to the six month period to 31 December 2019, as well as the remaining six months of the current financial year.

OutlookIn the period since the recapitalisation, the Company has continued to receive inbound leads with regards to potential platform acquisitions as well as introductions to sector-leading management teams looking to deploy a buy-and-build strategy utilising a listed vehicle. While there is no certainty these discussions will lead to a new executive team being appointed, or a platform acquisition being completed, we look forward to updating shareholders with our progress in due course.

The directors believe that the recent market disruption, due primarily to the Coronavirus pandemic, will provide opportunities to deploy capital at more reasonable valuations, where the Company is able to provide an innovative solution to public or private businesses, unlocking growth potential and delivering exceptional shareholder value through a buy-and-build strategy.

RESPONSIBILITY STATEMENT

Each of the Directors confirms that, to the best of their knowledge:

(a) these Consolidated Interim Financial Statements, which have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit or loss of Wilmcote; and

(b) these Consolidated Interim Financial Statements comply with the requirements of Rule 18 of the AIM Rules for Companies and Article 106 of the Companies (Jersey) Law 1991.

Neither the Company nor the Directors accept any liability to any person in relation to the interim financial report except to the extent that such liability could arise under applicable law.

Details on the Company's Board of Directors can be found on the Company website at www.wilmcoteplc.com.

James CorsellisChairman26 March 2020

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

Six monthsended

 

Six monthsended

 

 

31 December

 

31 December

 

 

2019

 

2018

 

Note

Unaudited

 

Unaudited

 

 

£'000

 

£'000

 

 

 

 

 

Administrative expenses

7

(1,721)

 

(1,695)

Total operating loss

 

(1,721)

 

(1,695)

 

 

 

 

 

Finance income

5

-

 

14

Income tax

8

-

 

-

Loss for the period

 

(1,721)

 

(1,681)

Total other comprehensive income

 

-

 

-

Total comprehensive loss for the period attributable to owners of the parent

 

 

(1,721)

 

 

(1,681)

 

 

 

 

 

Loss per ordinary share

 

 

 

 

Basic and diluted (£)

9

(0.020)

 

(0.081)

 

 

The Group's activities derive from continuing operations.

 

The Notes on pages 10 to 17 form an integral part of these Consolidated Interim Financial Statements.

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

 

As at

31 December

2019

 

As at

30 June

2019

 

Note

Unaudited

 

Audited

 

 

£'000

 

£'000

Assets

 

 

 

 

Non-current assets

 

 

 

 

Property, plant & equipment

 

-

 

2

Total non-current assets

 

-

 

2

 

 

 

 

 

Current assets

 

 

 

 

Trade and other receivables

11

147

 

285

Cash and cash equivalents

12

6,450

 

7,525

Total current assets

 

6,597

 

7,810

 

 

 

 

 

Total assets

 

6,597

 

7,812

 

 

 

 

 

Equity and liabilities

 

 

 

 

Equity

 

 

 

 

Stated capital

14

30,870

 

24,370

Share-based payment reserve

 

205

 

288

Accumulated losses

 

(24,652)

 

(23,362)

Total equity

 

6,423

 

1,296

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

13

174

 

6,516

Total liabilities

 

174

 

6,516

 

 

 

 

 

Total equity and liabilities

 

6,597

 

7,812

 

The Notes on pages 10 to 17 form an integral part of these Consolidated Interim Financial Statements.

 

The financial statements were approved by the Board of Directors on 26 March 2020 and were signed on its behalf by:

 

 

James Corsellis Mark Brangstrup Watts

Chairman Director

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

 

 Stated capital

 

Share based payment reserve

 

Accumulated

losses

 

Total equity

 

 

 

£'000

 

£'000

 

£'000

 

£'000

Balance as at 1 July 2019

 

 

 24,370

 

288

 

(23,362)

 

1,296

Issue of shares

 

 

6,500

 

-

 

-

 

6,500

Loss and total comprehensive loss for the period

 

 

-

 

-

 

(1,721)

 

(1,721)

Share-based payment expense

 

 

-

 

348

 

-

 

348

Cancellation of shares

 

 

-

 

(431)

 

431

 

-

Balance as at 31 December 2019

 

 

30,870

 

205

 

(24,652)

 

6,423

 

 

 

 

 Stated capital

 

Share based payment reserve

 

Accumulated

losses

 

Total equity

 

 

 

£'000

 

£'000

 

£'000

 

£'000

Balance as at 1 July 2018

 

 

 24,370

 

285

 

(13,196)

 

11,459

Loss and total comprehensive loss for the period

 

 

-

 

-

 

(1,681)

 

(1,681)

Share-based payment expense

 

 

-

 

 35

 

-

 

35

Balance as at 31 December 2018

 

 

24,370

 

320

 

(14,877)

 

9,813

 

The Notes on pages 10 to 17 form an integral part of these Consolidated Interim Financial Statements.

CONSOLIDATED STATEMENT OF CASH FLOWS

 

 

For six months ended

31 December

2019

 

For six months ended

31 December

2018

 

Note

Unaudited

 

Unaudited

 

 

£'000

 

£'000

 

 

 

 

 

Operating activities

 

 

 

 

Loss for the period

 

(1,721)

 

(1,681)

 

 

 

 

 

Adjustments to reconcile total operating loss to net cash flows:

 

 

 

 

Deduct finance income

 

-

 

(14)

Add back depreciation expense

 

2

 

1

Add back share based payment expense

 

348

 

35

Working capital adjustments:

 

 

 

 

Decrease in trade and other receivables and

prepayments

 

83

 

305

Decrease in trade and other payables

 

(6,251)

 

(7,891)

Interest received

 

-

 

14

Net cash flows used in operating activities

 

(7,539)

 

(9,231)

 

 

 

 

 

Financing activities

 

 

 

 

Proceeds from issue of ordinary share capital

 14

6,500

 

-

Payment on cancellation of WHJ Limited A Shares

 

(36)

 

-

Net cash flows from financing activities

 

6,464

 

-

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

 

(1,075)

 

(9,231)

Cash and cash equivalents at the beginning of the period

 

7,525

 

19,473

Cash and cash equivalents at the end of the period

12

6,450

 

10,242

 

The Notes on pages 10 to 17 form an integral part of these Consolidated Interim Financial Statements.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1. GENERAL INFORMATION

Wilmcote Holdings plc (the "Company"), an "investing company" for the purposes of the AIM Rules for Companies ("AIM Rules"), is incorporated in Jersey (company number 123424) and domiciled in the United Kingdom. It is a public limited company with registered office at One Waverley Place, Union Street, St Helier, Jersey, JE1 1AX and a UK Establishment (BR019423) address of 11 Buckingham Street, London, WC2N 6DF. The Company is the holding company of a number of subsidiaries (together with the Company, collectively "Wilmcote" or the "Group"), as detailed in Note 10.

 

2. ACCOUNTING POLICIES

(a) Basis of preparation

The Consolidated Interim Financial Statements have been prepared in accordance with the IAS 34 Interim Financial Reporting and are presented on a condensed basis. The Consolidated Interim Financial Statements do not constitute statutory accounts within the meaning of Article 105 of the Companies (Jersey) Law 1991. All values are rounded to the nearest thousand (£000) except where otherwise indicated.

 

The Consolidated Interim Financial Statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Group's Annual Report and Consolidated Financial Statements for the year ended 30 June 2019, which is available on the Company's website, www.wilmcoteplc.com.

 

(b) Going concern

The Consolidated Interim Financial Statements have been prepared on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall due within the next 12 months.

(c) New standards and amendments to International Financial Reporting Standards

Standards, amendments and interpretation effective and adopted by the Group

The accounting policies adopted in the preparation of these Consolidated Interim Financial Statements are consistent with those followed in the preparation of the Group's audited consolidated financial statements for the period ended 30 June 2019, which were prepared in accordance with the International Financial Reporting Standards ("IFRS"), as adopted by the European Union, updated to adopt those standards which became effective for periods starting on or before 1 January 2019. None of the new standards have had a material impact on the Group.

Standards issued but not yet effective

The following standards are issued but not yet effective. The Group intends to adopt these standards, if applicable, when they become effective. It is not expected that these standards will have a material impact on the Group.

Standard

Effective date

Amendments to IFRS 9, IAS 39 and IFRS 7: Interest Rate Benchmark Reform

1 January 2020

Amendments to IAS 1 and IAS 8: Definition of Material

1 January 2020

Amendments to References of the Conceptual Framework in IFRS Standards

1 January 2020

IFRS 14 Regulatory Deferral Accounts

To be confirmed*

Amendments to IFRS 3 Business Combinations

To be confirmed**

Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current or Non-current

To be confirmed**

IFRS 17 Insurance Contracts

To be confirmed**

* the EU has decided not to endorse the interim standard and to wait for the final standard** subject to EU endorsement

3. CRITICAL ACCOUNTING JUDGEMENTS AND ESTIMATES

The preparation of the Consolidated Interim Financial Statements under IFRS requires the Directors to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. Estimates and judgements are continually evaluated and are based on historical experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.

For the period and at the period end, the Directors do not consider that they have made any significant estimates, judgements or assumptions which would affect the balances and results reported in these financial statements.

4. SEGMENT INFORMATION

The Board of Directors is the Group's chief operating decision-maker. As the Group has not yet commenced trading, the Board of Directors considers the Group as a whole for the purposes of assessing performance and allocating resources, and therefore the Group has one reportable operating segment.

5. FINANCE INCOME

 

For six months

ended 31 December 2019

 

For six months

ended 31 December 2018

 

£'000

 

£'000

Interest on bank deposits

-

 

14

 

-

 

14

 

6. EMPLOYEES AND DIRECTORS

(a) Staff costs for the Group during the period:

 

For six months

ended 31 December 2019

 

For six months

ended 31 December 2018

 

£'000

 

£'000

Wages and salaries

604

 

383

Social security costs

83

 

51

Short term employment benefits

3

 

4

Other employment related costs

-

 

50

Total employment cost expense 

690

 

488

 

(b) Key management compensation

The Board considers the Directors of the Company, along with certain senior employees, to be the key management personnel of the Group.

 

The following table details the aggregate compensation due to key management personnel over the period.

 

For six months

ended 31 December 2019

 

For six months

ended 31 December 2018

 

£'000

 

£'000

Salaries, bonus, termination payments and short term employee benefits

594

 

307

 

594

 

307

 

7. EXPENSES BY NATURE

 

For six monthsended 31 December 2019

 

For six months ended 31 December 2018

 

£'000

 

£'000

Group expenses by nature

 

 

 

Employment costs

690

 

488

Non-recurring project, professional and diligence costs

96

 

326

Travel and entertaining

11

 

30

Office costs

29

 

34

Professional support

540

 

760

Share based payment expense

348

 

35

Other expenses

7

 

22

 

1,721

 

1,695

 

8. INCOME TAX EXPENSE

 

 

For six monthsended 31 December 2019

 

For six months ended 31 December 2018

 

£'000

 

£'000

Analysis of tax in period

 

 

 

Current tax on profits for the period

-

 

-

Total current tax

-

 

-

 

Reconciliation of effective rate and tax charge:

 

For six monthsended 31 December 2019

 

For six months ended 31 December 2018

 

£'000

 

£'000

Loss on ordinary activities before tax

(1,721)

 

(1,681)

Loss on ordinary activities multiplied by the rate of corporation tax in the UK of 19% (2018: 19%)

(327)

 

(319)

Effects of:

 

 

 

Losses carried forward for which no deferred tax recognised

327

 

319

Total taxation charge

-

 

-

As at 31 December 2019, cumulative tax losses available to carry forward against future trading profits were £24,652,000 subject to agreement with HM Revenue & Customs. Prior to a Platform Acquisition, there is no certainty as to future profits and no deferred tax asset is recognised in relation to these carried forward losses.

 

9. LOSS PER ORDINARY SHARE

Basic EPS is calculated by dividing the profit attributable to equity holders of a company by the weighted average number of ordinary shares in issue during the year. Diluted EPS is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares. The weighted average number of shares has not been adjusted in calculating diluted EPS as there are no instruments which have a current dilutive effect.

 

Refer to Note 17 of the Group's Annual Report and Consolidated Financial Statements for the period ended 30 June 2019 for instruments that could potentially dilute basic EPS in the future.

 

For six months ended 31 December 2019

 

For six months ended 31 December 2018

Loss attributable to owners of the parent (£'000)

(1,721)

 

(1,681)

Weighted average number of ordinary shares in issue

87,952,901

 

20,833,336

Weighted average number of ordinary shares for diluted EPS

87,952,901

 

20,833,336

 

10. INVESTMENTS

Principal subsidiary undertakings of the Group

The Company owns, directly or indirectly, the whole of the issued and fully paid ordinary share capital of its subsidiary undertakings.

 

Principal subsidiary undertakings of the Group as at 31 December 2019 are presented below:

 

 

 

Subsidiary

Nature of business

Country of incorporation

Proportion of ordinary shares held by parent

Proportion of ordinary shares held by the Group

 

 

 

 

 

WHJ Limited

 Incentive vehicle

Jersey

100%

100%

WCH Group Limited

Dormant company

England

100%

100%

Wilmcote Group Limited

Dormant company

England

0%

100%

Arrow US Holdings Inc

Acquisition vehicle

United States

0%

100%

Arrow Canadian Holdings Limited

Dormant company

Canada

0%

100%

There are no restrictions on the Company's ability to access or use the assets and settle the liabilities of the Company's subsidiaries.

The registered office of WHJ Limited is One Waverley Place, Union Street, St Helier, Jersey, JE1 1AX. The registered office of Wilmcote Group Limited and WCH Group Limited is 11 Buckingham Street, London, WC2N 6DF. The registered address for Arrow US Holdings Limited is 1209 Orange Street, Wilmington, New Castle, Delaware, 19801. The registered address for Arrow Canadian Holdings Limited is 1055 West Hastings Street, Suite 1700, Vancouver, BC, V6E 2E9.

 

11. TRADE AND OTHER RECEIVABLES

 

As at 31 December 2019

 

As at 30 June

2019

 

£'000

 

£'000

Amounts receivable in one year:

 

 

 

Prepayments

26

 

45

Other receivables

-

 

55

VAT receivable

121

 

185

 

147

 

285

Other receivables are all current.

There is no material difference between the book value and the fair value of the receivables. Receivables are considered to be past due once they have passed their contracted due date.

 

12. CASH AND CASH EQUIVALENTS

 

 

As at 31 December 2019

 

As at 30 June

2019

 

£'000

 

£'000

Cash and cash equivalents

 

 

 

Cash at bank

6,450

 

7,525

 

6,450

 

7,525

 

Credit risk is managed on a group basis. Credit risk arises from cash and cash equivalents and deposits with banks and financial institutions. For banks and financial institutions, only independently rated parties with a minimum short-term credit rating of P-1, as issued by Moody's, are accepted. The utilisation of credit limits is regularly monitored.

 

13. TRADE AND OTHER PAYABLES

 

As at 31 December

2019

 

As at 30 June

2019

 

£'000

 

£'000

Amounts falling due within one year:

 

 

 

Trade payables

91

 

1,113

Accruals

83

 

5,312

A1 share liability

-

 

91

 

174

 

6,516

There is no material difference between the book value and the fair value of the trade and other payables.

14. STATED CAPITAL

 

As at 31 December

2019

 

As at 30 June

2019

Authorised

 

 

 

Unlimited ordinary shares of no par value

 

 

 

 

 

 

 

Issued

 

 

 

Ordinary shares of no par value

670,833,336

 

20,833,336

Stated capital (£'000)

30,870

 

24,370

 

On 13 December 2019 a further 650,000,000 ordinary shares of no par value were issued at £0.01 for an aggregate consideration of £6,500,000.

The holders of ordinary shares are entitled to receive dividends as declared and are entitled to one vote per share at meetings of the Company.

 

15. FINANCIAL INSTRUMENTS AND ASSOCIATED RISKS

The Group has the following categories of financial instruments at the period end:

 

As at 31 December 2019

 

As at 30 June

2019

 

£'000

 

£'000

Financial assets measured at amortised cost

 

 

 

Cash and cash equivalents

6,450

 

7,525

Other receivables

-

 

55

 

6,450

 

7,580

 

 

 

 

Financial liabilities measured at amortised cost

 

 

 

Trade and other payables

174

 

6,516

 

174

 

6,516

The fair value and book value of the financial assets and liabilities are materially equivalent.

The Group's risk management policies are established to identify and analyse the risks faced by the Group, to set appropriate risk limits and controls, and to monitor risks and adherence limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and the Group's activities.

Treasury activities are managed on a Group basis under policies and procedures approved and monitored by the Board. These are designed to reduce the financial risks faced by the Group which primarily relate to movements in interest rates.

As the Group's assets are predominantly cash and cash equivalents, market risk and liquidity risk are not currently considered to be material risks to the Group.

 

16. RELATED PARTY TRANSACTIONS

The AIM Rules define a related party as any (i) director of the Company or its subsidiary, (ii) a substantial shareholder, being any shareholders holding at least 10 per cent. of a share class or (iii) an associate of those parties identified in (i) or (ii).

James Corsellis and Mark Brangstrup Watts are the managing partners of the Marwyn Group. Funds managed by Marwyn Asset Management Limited, of which James Corsellis and Mark Brangstrup Watts are both non-executive directors and of which they are the ultimate beneficial owners, hold 95.36% of the Company's issued ordinary shares.

James Corsellis and Mark Brangstrup Watts have a beneficial interest in the A2 Shares as described in note 17 of the Group's Annual Report and Consolidated Financial Statements for the year ended 30 June 2019.

James Corsellis and Mark Brangstrup Watts are the managing partners of Marwyn Capital LLP which provides corporate finance advice and various office and finance support services to the Company. During the period Marwyn Capital LLP charged £370,000 (excluding VAT) (2018: £390,000) in respect of services supplied, £8,000 (excluding VAT) (2018: £7,000) for James Corsellis' and Mark Brangstrup Watts' directors' fees and £1,000 (2018: £3,000) in respect of expenses incurred on behalf of the Group. Marwyn Capital LLP was owed an amount of £52,000 (30 June 2019: £73,000) at the balance sheet date.

James Corsellis and Mark Brangstrup Watts are the ultimate beneficial owners of Axio Capital Solutions Limited which provides financial and accounting services, transactional support, company secretarial and administrative services to the Group. During the period Axio Capital Solutions Limited charged £253,000 (2018: £270,000) in respect of services supplied and £3,000 (2018: £2,000) in respect of expenses incurred on behalf of the Group. Axio Capital Solutions Limited was owed an amount of £30,000 (30 June 2019: £27,000) at the balance sheet date.

James Corsellis and Mark Brangstrup Watts are the ultimate beneficial owners of Marwyn Partners Limited and Marwyn Investment Management LLP which both incurred costs on behalf of the Group which they recharged. During the period Marwyn Partners Limited charged £6,000 (2018: £36,000) in respect of recharged costs and Marwyn Investment Management LLP charged £39,000 (2018: £27,000) in respect of recharged costs. Marwyn Investment Management LLP was owed an amount of £9,000 (30 June 2019: £19,000) at the balance sheet date and there was no outstanding balance with Marwyn Partners Limited (30 June 2019: £17,000).

Key management personnel remuneration is disclosed in Note 6.

17. COMMITMENTS AND CONTINGENT LIABILITIES

There were no commitments or contingent liabilities outstanding at 31 December 2019 that requires disclosure or adjustment in these financial statements.

18. POST BALANCE SHEET EVENTS

There have been no material post balance sheet events that would require disclosure or adjustment to these financial statements. 

ADVISERS

Nominated Adviser and Broker Numis Securities LimitedThe London Stock Exchange Building10 Paternoster SquareLondon, EC4M 7LT

Company Secretary and AdministratorAxio Capital Solutions Limited One Waverley PlaceUnion StreetSt Helier, Jersey, JE1 1AX

RegistrarLink Registrars (Jersey) Limited12 Castle StreetSt Helier, Jersey, JE2 3RT

Solicitors to the Company (as to English law)Covington & Burling LLP265 StrandLondon, WC2R 1BH

Principal Bankers Barclays Bank plc39/41 Broad StreetSt Helier Jersey, JE4 8PV 

Solicitors to the Company (as to Jersey law)Ogier44 EsplanadeSt Helier, Jersey, JE4 9WG

AuditorPricewaterhouseCoopers LLP 1 Embankment Place London, WC2N 6RH 

Corporate Finance Adviser Marwyn Capital LLP 11 Buckingham Street London, WC2N 6DF 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR PPUCGWUPUPUQ
Date   Source Headline
14th Jan 202110:06 amRNSChange of Name to Marwyn Acquisition Company Plc
31st Dec 202012:40 pmRNSResult of AGM
11th Dec 20207:00 amRNSNotice of AGM
4th Nov 20207:00 amRNSAnnual Financial Report
27th Mar 20207:00 amRNSInterim results for the 6 months ended 31 Dec 2019
17th Dec 20195:26 pmRNSHolding(s) in Company
16th Dec 20195:07 pmRNSHolding(s) in Company
16th Dec 20195:06 pmRNSHolding(s) in Company
12th Dec 201912:00 pmRNSResult of AGM
12th Dec 20197:00 amRNSOpen Offer Results
29th Nov 20194:32 pmRNSCorporate Broker Update
25th Nov 20197:00 amRNSNotice of AGM & Proposed Open Offer
25th Nov 20197:00 amRNSFinal Results
21st Oct 20197:00 amRNSDirectorate Change
11th Oct 20197:30 amRNSRestoration - Wilmcote Holdings Plc
11th Oct 20197:00 amRNSStatement regarding potential acquisition
2nd Oct 20197:00 amRNSStatement regarding potential acquisition
18th Jul 20196:24 pmRNSStatement regarding potential acquisition
1st Jul 20197:00 amRNSAppointment of Kevin Dangerfield as CFO
4th Jun 20192:05 pmRNSStatement re potential acquisition
4th Jun 20192:00 pmRNSSuspension - Wilmcote Holdings Plc
30th Apr 20197:00 amRNSAppointment of Kevin Dangerfield as CFO
28th Mar 20197:00 amRNSInterim results for the 6 months ended 31 Dec 2018
20th Nov 201812:39 pmRNSResults of Annual General Meeting
29th Oct 20187:00 amRNSNotice of Annual General Meeting
1st Oct 20187:00 amRNSNED Appointment
28th Sep 20187:00 amRNSFinal Results
25th Sep 20187:00 amRNSBoard Appointments
23rd Jul 20187:00 amRNSYear End Trading Update
18th Jun 20182:45 pmRNSRestoration - Wilmcote Holdings plc
18th Jun 20182:45 pmRNSStatement re Arysta LifeScience
7th Jun 20187:30 amRNSSuspension - Wilmcote Holdings plc
7th Jun 20187:00 amRNSStatement re media speculation
15th Mar 20187:00 amRNSInterim results
28th Nov 20172:41 pmRNSResult of AGM
9th Nov 20177:00 amRNSNotice of Annual General Meeting
21st Sep 20172:28 pmRNSHolding(s) in Company
21st Aug 20172:12 pmRNSHolding(s) in Company
21st Aug 20172:06 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSWilmcote successfully lists on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.